- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01728896
Patient-Initiated and ConTrolled Oral Refeeding (PICTOR) (PICTOR)
A Randomized Controlled Trial of Patient-Initiated and ConTrolled Oral Refeeding in Acute Pancreatitis
The first step in treating patients with acute pancreatitis is to provide pain relief and intravenous fluids to keep them comfortable. As the pain subsides and patient starts to feel better food and fluids by mouth are restarted. This is done to rest the pancreas which is the organ that has been inflamed.
In some patients when food by mouth restarts they have pain and as a consequence they have a longer stay in hospital. It is thought that patients who have little pain and are within 24 hours of admission to hospital do well if they control their own food intake. This is in contrast to the usual treatment where the treating team advise when eating should restart.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Auckland, Nouvelle-Zélande
- University of Auckland; Auckland City Hospital
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- diagnosis of acute pancreatitis
- age > 18 years
- written informed consent
Exclusion Criteria:
- ongoing need for opiates
- >96 hours after onset of symptoms
- chronic pancreatitis
- post-ERCP pancreatitis
- intraoperative diagnosis
- pregnancy
- malignancy
- received nutrition before randomisation
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Aucune intervention: Gestion conventionnelle
|
|
Expérimental: Patient-controlled oral refeeding
Patients will be allowed to drink and eat hospital food freely as tolerated.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
---|---|
Oral food intolerance
Délai: Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Time from admission until tolerance of oral food
Délai: Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
|
Total length of hospital stay
Délai: Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
|
Need for opiates
Délai: Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Need for opiates is defined when one (or more) of the following has been administered:
|
Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Change in pain intensity
Délai: Baseline and 24, 48, 72h after randomisation
|
Baseline and 24, 48, 72h after randomisation
|
|
Progression of acute pancreatitis severity
Délai: Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
To be defined according to the 2012 determinant-based classification of acute pancreatitis severity
|
Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Hospital readmission
Délai: 2 weeks after hospital discharge
|
2 weeks after hospital discharge
|
|
Local and systemic complications
Délai: Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
To be defined according to the 2012 determinant-based classification of acute pancreatitis severity
|
Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Number and type of interventions during hospital stay
Délai: Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
|
Time from admission until first flatus
Délai: Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
|
Change in blood glucose
Délai: Baseline and 24, 48, 72h after randomisation
|
Baseline and 24, 48, 72h after randomisation
|
|
Change in plasma C-reactive protein
Délai: Baseline and 24, 48, 72h after randomisation
|
Baseline and 24, 48, 72h after randomisation
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- NTX/12/06/051
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Patient-controlled oral refeeding
-
Cliniques universitaires Saint-Luc- Université...Complété
-
Rigshospitalet, DenmarkRecrutementTrouble dépressif majeur | Comportement sexuel | Changement d'humeur | Trouble de l'humeur | Affect modifié | Affect émoussé | Mécanisme de la drogueDanemark
-
General and Teaching Hospital CeljeInconnue
-
Case Comprehensive Cancer CenterRetiré